APPLICATION
NDA016943
TYPE
NDA
ORIGINAL APPROVAL
1971-08-06
LATEST ACTION
1997-01-09
ROUTE
TOPICAL
DOSAGE FORM
SOLUTION
MARKETING STATUS
Discontinued
Products
HALOTEXDiscontinued
HALOPROGIN 1% · SOLUTION · TOPICAL
Approval history
1997-01-09Labeling · Supplement 9AP
1990-01-26Labeling · Supplement 10AP
1971-08-06Type 3 - New Dosage Form · Original · priorityAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.